| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.26 | 5e-09 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-06 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |